Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatotoxicity from propylthiouracil

S A Westphal1

  • 1Department of Medicine, Maricopa Medical Center, Phoenix, AZ 85008.

Southern Medical Journal
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Propylthiouracil can cause rare but serious liver damage (hepatotoxicity), potentially due to immune responses. This case highlights the unpredictable nature of this severe side effect in hyperthyroidism treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetic ketoacidosis in association with acanthosis nigricans.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001
Same author

Potential cardiovascular effects of thiazolidinediones.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001
Same author

Concurrent diagnosis of acromegaly and diabetic ketoacidosis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001
Same author

Acute metabolic response to high-carbohydrate, high-starch meals compared with moderate-carbohydrate, low-starch meals in subjects with type 2 diabetes.

Diabetes care·1998
Same author

Disseminated coccidioidomycosis associated with hypercalcemia.

Mayo Clinic proceedings·1998
Same author

Adrenomyeloneuropathy presenting in adulthood.

The Western journal of medicine·1998
Same journal

The Five Essential Concepts of Developmental Medicine: A Medical Paradigm for People with Developmental Disabilities.

Southern medical journal·2026
Same journal

α-Gal Syndrome in the South: Why We Need Treatment Trials, Not Just Tick Prevention.

Southern medical journal·2026
Same journal

Association between Main Pancreatic Duct Size, Comorbidities, and Fistula Formation after Whipple Procedure for Pancreatic Cancer.

Southern medical journal·2026
Same journal

Impact of Temperature Variation on Patients with Acute Severe Asthma.

Southern medical journal·2026
Same journal

Assessing the Accuracy and Reliability of ChatGPT-4 to Answer Clinical EHR Messages in Sports Medicine.

Southern medical journal·2026
Same journal

Diagnostic Utility and Clinical Implications of Inpatient Fecal Occult Blood Testing.

Southern medical journal·2026
See all related articles

Area of Science:

  • Endocrinology
  • Hepatology
  • Pharmacology

Background:

  • Propylthiouracil (PTU) is a widely prescribed medication for managing hyperthyroidism, particularly Graves' disease.
  • While effective, PTU is associated with a spectrum of adverse effects, including rare but severe hepatotoxicity.
  • The exact mechanisms and identifiable risk factors for PTU-induced liver injury remain poorly understood, making its prediction challenging.

Observation:

  • This report details a clinical case of acute hepatitis that emerged during propylthiouracil treatment in a patient with Graves' disease.
  • The patient's presentation underscores the potential for serious hepatic complications even with standard PTU therapy.

Findings:

  • Propylthiouracil-induced hepatotoxicity represents a rare but critical adverse drug reaction.

Related Experiment Videos

  • The development of acute hepatitis during PTU therapy suggests a potential immune-mediated pathway, although specific risk factors are not established.
  • The unpredictable onset and severity of this side effect pose a significant clinical concern.

    • Implications:

    • Clinicians should maintain a high index of suspicion for liver injury in patients treated with propylthiouracil, especially those with Graves' disease.
    • Further research is warranted to elucidate the immunopathogenesis of PTU-induced hepatotoxicity and identify predictive biomarkers.
    • Early recognition and prompt management are crucial for mitigating the potentially fatal consequences of propylthiouracil-induced liver injury.